Genocea Biosciences, Inc. (GNCA) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 ACORN PARK DRIVE
CAMBRIDGE, MA 02140
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2022
MRQ
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 37,14879,76940,12726,36112,27363,362
Cash and cash equivalents 37,14879,76940,12726,36112,27327,424
Short-term investments      35,938
Deferred costs    110571339
Other undisclosed current assets 4,6742,4581,457586237587
Total current assets: 41,82282,22741,58427,05713,08164,288
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  30150
Operating lease, right-of-use asset 7,4209,2786,156
Property, plant and equipment 5,8415,1232,6172,5823,4604,871
Restricted cash and investments 631631631316316316
Other noncurrent assets 2531,2041,4731,160631421
Total noncurrent assets: 14,14516,26611,0274,0584,4075,608
TOTAL ASSETS: 55,96798,49352,61131,11517,48869,896
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3,5223,3132,7983,8065,3465,133
Employee-related liabilities 3,0222,7792,2452,1471,8302,090
Accounts payable 5005345531,6593,5163,043
Deferred revenue 1,7001,641 
Debt 4,64113,8841,1175,2576,6593,149
Restructuring reserve     44 
Other undisclosed current liabilities 8,8206,1572,3661,6693,7302,088
Total current liabilities: 18,68324,9956,28110,73215,77910,370
Noncurrent Liabilities
Long-term debt and lease obligation 4,1468,39818,8029,5657,65213,809
Long-term debt, excluding current maturities 4,146 13,4079,5657,65213,809
Finance lease, liability   22
Liabilities, other than long-term debt    11107176
Other liabilities    11107176
Operating lease, liability  8,3985,373
Other undisclosed noncurrent liabilities 6,06347,7202,4863,472  
Total noncurrent liabilities: 10,20964,51621,28813,0487,75913,985
Total liabilities: 28,89289,51127,56923,78023,53824,355
Equity
Equity, attributable to parent, including: 27,0758,98225,0427,335(6,050)45,541
Common stock 585327872928
Additional paid in capital 434,881383,597355,268298,551258,114252,996
Accumulated deficit (407,864)(374,668)(330,954)(292,004)(264,193)(207,483)
Other undisclosed equity, attributable to parent   701701  
Total equity: 27,0758,98225,0427,335(6,050)45,541
TOTAL LIABILITIES AND EQUITY: 55,96798,49352,61131,11517,48869,896

Income Statement (P&L) ($ in thousands)

3/31/2022
TTM
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues 1,6411,359   235
Revenue, net 235
Sublease income 1,400  
Gross profit: 1,6411,359   235
Operating expenses (53,734)(48,348)(38,989)(39,518)(55,255)(48,480)
Operating loss: (52,093)(46,989)(38,989)(39,518)(55,255)(48,245)
Nonoperating income (expense) 18,8973,2753911,707(1,455)(1,328)
Investment income, nonoperating     250410
Other nonoperating expense (122)(4,234)(1)(2,029)  
Interest and debt expense (1,121)(1,380)(946)(1,021)(1,705)(1,738)
Loss from continuing operations: (34,317)(45,094)(39,896)(28,832)(58,415)(51,311)
Loss before gain (loss) on sale of properties:(34,317)(45,094)(39,896)(28,832)(58,415)(51,311)
Net loss: (34,317)(45,094)(39,896)(28,832)(58,415)(51,311)
Other undisclosed net income attributable to parent 1,1211,3809461,0211,7051,738
Net loss attributable to parent: (33,196)(43,714)(38,950)(27,811)(56,710)(49,573)
Preferred stock dividends and other adjustments  8,067    
Other undisclosed net loss available to common stockholders, basic  (16,134)    
Net loss available to common stockholders, diluted: (33,196)(51,781)(38,950)(27,811)(56,710)(49,573)

Comprehensive Income ($ in thousands)

3/31/2022
TTM
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss: (34,317)(45,094)(39,896)(28,832)(58,415)(51,311)
Comprehensive loss: (34,317)(45,094)(39,896)(28,832)(58,415)(51,311)
Other undisclosed comprehensive income, net of tax, attributable to parent 1,1211,3809461,0211,7051,738
Comprehensive loss, net of tax, attributable to parent: (33,196)(43,714)(38,950)(27,811)(56,710)(49,573)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: